Go Ad-Free
logoThe People's Perspective on Medicine

Is Ketamine a Solution for Severe Depression?

Q. I participated in two clinical trials of ketamine for depression. The infusion was not pleasant, but a few hours later my depression was mysteriously lifted. It was as though someone carefully cleaned, polished and rejuvenated every cell in my brain. It was not a feeling of being high; it was completely different from anything I had ever experienced in my entire life.

Unfortunately, it only lasted a few days. When it went away, the return to life as I had always known it was horrible. They told me up front it is a clinical trial and the drug is not available for depression treatment. But it is an FDA-approved medication. Any MD could prescribe it, but no one has been willing to administer it.

I have felt closer to suicide at times since I found out how good other people feel every day. I hope ketamine will soon be approved for severe depression.

A. Major depression like yours is challenging to treat. It can take weeks for current antidepressants to start working. Clinical trials reveal that only about a third of patients achieve good results, even after optimal therapy (American Journal of Psychiatry, Nov. 2006).

Ketamine (Ketalar) is a unique injectable anesthetic that has been used in surgery since the early 1970s. More recently, scientists have been studying ketamine for the treatment of major depression.

Preliminary studies suggest that ketamine may relieve severe depression within hours for up to two-thirds of those with treatment-resistant depression (Clinical Pharmacology & Therapeutics, Feb. 2012). This is still very much an experimental approach that has not been approved by the FDA. Most doctors are probably reluctant to prescribe ketamine for depression because the effect is short lived and the drug can cause hallucinations and changes in heart rate and blood pressure.

For more information on this approach to treating depression, listen to this report from NPR.

You may also find our Guide to Dealing with Depression of value.

Another valuable resource is an interview with Stephen Ilardi, PhD. His insights on depression could be very helpful.

2/14/19 redirected: https://www.peoplespharmacy.com/articles/will-fda-approve-esketamine-nasal-spray-for-depression/

Rate this article
star-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-empty
3- 2 ratings
About the Author
Terry Graedon, PhD, is a medical anthropologist and co-host of The People’s Pharmacy radio show, co-author of The People’s Pharmacy syndicated newspaper columns and numerous books, and co-founder of The People’s Pharmacy website. Terry taught in the Duke University School of Nursing and was an adjunct assistant professor in the Department of Anthropology. She is a Fellow of the Society of Applied Anthropology. Terry is one of the country's leading authorities on the science behind folk remedies..
Tired of the ads on our website?

Now you can browse our website completely ad-free for just $5 / month. Stay up to date on breaking health news and support our work without the distraction of advertisements.

Browse our website ad-free
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.